We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $59.6M
1-Year Est. Return 181.61%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+181.61%
3 Year Est. Return
+519.89%
5 Year Est. Return
+603.37%
10 Year Est. Return
+6,669.07%
AUM
$270M
AUM Growth
-$5.09M
Cap. Flow
+$1.98M
Cap. Flow %
0.73%
Top 10 Hldgs %
77.59%
Holding
68
New
41
Increased
2
Reduced
6
Closed
16

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$98.7M
2
GOSS icon
Gossamer Bio
GOSS
+$8.61M
3
PM icon
Philip Morris
PM
+$6.2M
4
CRBG icon
Corebridge Financial
CRBG
+$5.14M
5
ARGX icon
argenx
ARGX
+$4.45M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$144M
2
HYPR icon
Hyperfine
HYPR
+$3.89M
3
AMT icon
American Tower
AMT
+$3.83M
4
ACI icon
Albertsons Companies
ACI
+$3.34M
5
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$2.91M

Sector Composition

Rank Sector Weight
1 Miscellaneous 70.59%
2 Healthcare 18.97%
3 Financials 3.03%
4 Consumer Staples 2%
5 Materials 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
Invesco QQQ Trust
QQQ
$477B
$87.4M 32.41%
+327,000
New +$98.7M
VTI icon
2
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$85.1M 31.55%
474,000
-722,400
-60% -$144M
GOSS icon
3
Gossamer Bio
GOSS
$65.6M
$8.31M 3.08%
+8,668
New +$8.61M
PM icon
4
Philip Morris
PM
$304B
$5.4M 2%
+65,000
New +$6.2M
CRBG icon
5
Corebridge Financial
CRBG
$15.5B
$4.92M 1.83%
+250,000
New +$5.14M
ARGX icon
6
argenx
ARGX
$61.6B
$4.24M 1.57%
+12,000
New +$4.45M
ANTX icon
7
AN2 Therapeutics
ANTX
$204M
$4.05M 1.5%
233,330
– –
SLVM icon
8
Sylvamo
SLVM
$1.4B
$3.05M 1.13%
+90,000
New +$3.42M
SLGC
9
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$2.9M 1.08%
1,000,000
+75,000
+8% +$316K
CMPX icon
10
Compass Therapeutics
CMPX
$353M
$2.81M 1.04%
1,230,441
– –
CCL icon
11
Carnival Corporation Ltd
CCL
$30.9B
$2.56M 0.95%
+364,666
New +$3.53M
DYN icon
12
Dyne Therapeutics
DYN
$3.46B
$2.54M 0.94%
200,000
-119,536
-37% -$1.37M
BHVN icon
13
Biohaven
BHVN
$1.92B
$2.52M 0.93%
+409,200
New +$2.97M
CNM icon
14
Core & Main
CNM
$7.49B
$2.5M 0.93%
+110,000
New +$2.57M
RVNC
15
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.29M 0.85%
+85,000
New +$1.72M
AKRO
16
DELISTED
Akero Therapeutics
AKRO
$2.21M 0.82%
+65,000
New +$995K
PLRX icon
17
Pliant Therapeutics
PLRX
$72.4M
$2.09M 0.77%
+100,000
New +$1.91M
ALHC icon
18
Alignment Healthcare
ALHC
$2.68B
$1.89M 0.7%
+160,000
New +$2.33M
KDNY
19
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.87M 0.69%
95,000
-145,000
-60% -$2.91M
EYPT icon
20
EyePoint Inc
EYPT
$366M
$1.74M 0.65%
+220,000
New +$2.04M
DCGO icon
21
DocGo
DCGO
$37.1M
$1.74M 0.64%
175,000
-210,058
-55% -$1.9M
CRGY icon
22
Crescent Energy
CRGY
$4.84B
$1.68M 0.62%
+125,000
New +$1.83M
FULC icon
23
Fulcrum Therapeutics
FULC
$290M
$1.62M 0.6%
+200,000
New +$1.43M
SOFI icon
24
SoFi Technologies
SOFI
$22.8B
$1.56M 0.58%
+320,000
New +$2.02M
MLTX icon
25
MoonLake Immunotherapeutics
MLTX
$1.06B
$1.49M 0.55%
191,945
-8,055
-4% -$56.9K
1
2 3

Similar funds

ICM
Irth Capital Management New York $59.9M AUM 24.87% 1-Year Est. Return
AP
AlpInvest Partners Amsterdam, Netherlands $59.9M AUM 0.03% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $59.2M AUM 51.07% 1-Year Est. Return
CPM
Connective Portfolio Management New York $60.1M AUM 88.93% 1-Year Est. Return
WWP
Wise Wealth Partners Phoenix, Arizona $58.8M AUM 18.05% 1-Year Est. Return
CZI
Chan Zuckerberg Initiative Redwood City, California $58.5M AUM 31.79% 1-Year Est. Return
CT
ClearAlpha Technologies Greenwich, Connecticut $58.3M AUM 11.49% 1-Year Est. Return
GCS
Gordian Capital (Singapore) Singapore $58.2M AUM 99.93% 1-Year Est. Return

Monashee Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Monashee Investment Management held 68 positions worth $270M, down 1.9% from $275M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Monashee Investment Management's Q3 2022 filing shows 41 new, 2 increased, 6 reduced and 16 closed positions. Its largest new stake was Invesco QQQ Trust: 327,000 shares worth $87.4M. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $144M.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 82% a quarter earlier, followed by Healthcare and Financials.

  • Monashee Investment Management's largest Q3 2022 buy was Invesco QQQ Trust: 327,000 shares worth $87.4M.
  • Monashee Investment Management added most to ProFrac Holding in Q3 2022, an estimated $1.17M increase.
  • Monashee Investment Management's biggest Q3 2022 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $144M.
  • Monashee Investment Management fully exited Hyperfine in Q3 2022, selling an estimated $3.89M.
  • Monashee Investment Management's ten largest holdings make up 78% of its $270M portfolio in Q3 2022.
  • Monashee Investment Management opened 41 new positions and closed 16 in Q3 2022.
  • Monashee Investment Management's portfolio value fell 1.9% quarter-over-quarter to $270M.

Based on Monashee Investment Management's 13F filing for Q3 2022, filed 1 Nov 2022.